HCPLive

Less Than Half of Young Children Receive Recommended Flu Vaccination

 
THURSDAY, Jan. 17 (HealthDay News) -- Although the influenza vaccine is recommended for all children aged 6 months and older, less than 45 percent of young children are fully vaccinated and the health care burden of influenza is considerable, according to a study published online Jan. 6 in Pediatrics.

Katherine A. Poehling, M.D., M.P.H., from the Wake Forest School of Medicine in Winston-Salem, N.C., and colleagues analyzed the health care burden for influenza for a population of children younger than 5 years old. The children presented with fever and/or acute respiratory illness in inpatient and outpatient (emergency department or clinic) settings from 2004 to 2009, when influenza vaccination recommendations were expanded to all children 6 months of age and older. The population included 2,970 children from inpatient settings, 2,698 from emergency departments, and 2,920 from clinics.

The researchers found that the average annual hospitalization rates for influenza ranged from 0.4 to 1.0 per 1,000 children and were highest for infants younger than 6 months old. The annual percentage of children with influenza seen as outpatients ranged from 10 to 25 percent. Less than 45 percent of children 6 months and older were fully vaccinated against influenza. Among children hospitalized with influenza, 2 percent received antiviral drugs, while less than 1 percent of outpatient children with influenza received antiviral drugs.

"Despite expanded vaccination recommendations, many children are insufficiently vaccinated, and substantial influenza burden remains," Poehling and colleagues conclude.

Several authors disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text


Copyright © 2013 HealthDay. All rights reserved.
 
 

Most Popular

Recommended Reading

Researchers believe they have found a novel therapeutic to target a growth factor pathway that plays a role in liver cancer.
Another investigational diabetes drug appears to have promise for patients with nonalcoholic steatohepatitis, researchers reported at the International Liver Congress in Vienna, Austria.
The explosion in new drugs to treat hepatitis C is leading to predictions the viral infection will no longer be a major health problem. But before that can happen, much has to be done in the realm of public health, researchers said April 25 at the International Liver Congress in Vienna, Austria.
In addition to injection drug use, alcohol consumption puts people at risk of dying from hepatitis C infection by increasing the severity of the disease. A French research study spells out the risks.
$vAR$